Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Clinical cure rate | |||||
Systematic review |
936 people with otitis externa 3 RCTs in this analysis |
Clinical cure rate
14 to 28 days
with topical quinolone antibiotics with topical non-quinolone antibiotics Absolute results not reported |
Absolute rate difference 0.04 95% CI –0.01 to +0.08 P = 0.145 Only one RCT included in the meta-analysis compared topical quinolone alone versus topical non-quinolone alone, which may affect the generalisability of these results (see further information on studies for more details) |
Not significant | |
RCT |
601 people with any severity of acute diffuse otitis externa on otoscopy in a primary-care setting |
Clinical cure rate
1 month
215/242 (89%) with ofloxacin 206/232 (89%) with neomycin–hydrocortisone–polymyxin B drops |
P = 0.86 |
Not significant | |
Microbiological cure rate | |||||
RCT |
601 people with any severity of acute diffuse otitis externa on otoscopy in a primary-care setting |
Microbiological cure rate
1 month
85/93 (91%) with ofloxacin 97/103 (94%) with neomycin–hydrocortisone–polymyxin B drops |
P = 0.77 |
Not significant | |
Resolution | |||||
RCT |
55 people with moderate–severe acute or chronic diffuse otitis externa on otoscopy, in a secondary-care setting |
Resolution
1 month or until resolution of all symptoms and signs
27/34 (79%) with triamcinolone–neomycin 10/21 (48%) with hydrocortisone–neomycin–polymyxin B |
P <0.01 |
Effect size not calculated | triamcinolone–neomycin |